Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents
Roger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
March 24, 2009
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients
M Berge, R Guillemain, V Boussaud, et al.
Oncogene
|
January 23, 1997
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations
M Rossel, A Pasini, S Chappuis, et al.
European Journal of Clinical Pharmacology
|
November 2, 2010
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
Maud Berge, Romain Guillemain, David A Trégouet, et al.
Plos One
|
March 29, 2013
Expression of calcineurin activity after lung transplantation: a 2-year follow-up
Sylvia Sanquer, Catherine Amrein, Dominique Grenet, et al.
Oncogene
|
August 24, 2011
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1
H Gaude, N Aznar, A Delay, et al.
Therapeutic Drug Monitoring
|
March 17, 2016
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee
Christoph Seger, Maria Shipkova, Uwe Christians, et al.
Oncogene
|
July 8, 2014
A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties
R Dahmani, P-A Just, A Delay, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 25, 2018
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study
Claire A Aguilar, Bassem Hamandi, Christine Fegbeutel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure
Antonin Schmitt, Laurence Gladieff, Céline M Laffont, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents
Roger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
March 24, 2009
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients
M Berge, R Guillemain, V Boussaud, et al.
Oncogene
|
January 23, 1997
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations
M Rossel, A Pasini, S Chappuis, et al.
European Journal of Clinical Pharmacology
|
November 2, 2010
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
Maud Berge, Romain Guillemain, David A Trégouet, et al.
Plos One
|
March 29, 2013
Expression of calcineurin activity after lung transplantation: a 2-year follow-up
Sylvia Sanquer, Catherine Amrein, Dominique Grenet, et al.
Oncogene
|
August 24, 2011
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1
H Gaude, N Aznar, A Delay, et al.
Therapeutic Drug Monitoring
|
March 17, 2016
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee
Christoph Seger, Maria Shipkova, Uwe Christians, et al.
Oncogene
|
July 8, 2014
A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties
R Dahmani, P-A Just, A Delay, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 25, 2018
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study
Claire A Aguilar, Bassem Hamandi, Christine Fegbeutel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure
Antonin Schmitt, Laurence Gladieff, Céline M Laffont, et al.
Page
of 10